Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial. (2023)

First Author: Joharatnam-Hogan N
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-023-02310-1

PubMed Identifier: 37420000

Publication URI: http://europepmc.org/abstract/MED/37420000

Type: Journal Article/Review

Volume: 129

Parent Publication: British journal of cancer

Issue: 4

ISSN: 0007-0920